Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney...

cafead

Administrator
Staff member
  • cafead   Jun 05, 2018 at 10:32: AM
via
  • TRC101 met both primary and secondary endpoints
  • Partients reported improved quality of life scores
  • Approximately 3 million patients in the US alone are at risk for CKD metabolic acidosis

article source